Natera Inc · Q3 2020 earnings

Briefing

Natera reported an exceptional quarter with significant volume increase and strong revenue growth driven by new businesses.

Natera's Q3 2020 total revenues increased to $98.1 million compared to $77.9 million in Q3 2019, driven by a 39.5% increase in product revenues. The company processed 262,000 tests, including approximately 249,300 tests accessioned in its laboratory. Net loss was $58.3 million, or ($0.72) per diluted share, compared to a net loss of $23.1 million, or ($0.33) per diluted share, for the same period in 2019.

• Total revenues reached $98.1 million, a significant increase from $77.9 million in the third quarter of 2019.
• Product revenues increased by 39.5% compared to the third quarter of 2019.
• Natera processed 262,000 tests in the third quarter of 2020, including approximately 249,300 tests accessioned in its laboratory.
• The company is raising its 2020 revenue guidance.

Headline financials

Revenue & EPS history

Natera anticipates 2020 total revenue of $380 million to $390 million; 2020 cost of revenues to be approximately 51% to 54% of revenues; selling, general and administrative costs to be approximately $270 million to $280 million; research and development costs to be $90 million to $95 million, and net cash burn to be $140 million to $150 million.